AFRM vs OWL

AFRM's Piotroski F-Score of 7/9 indicates strong operational health, but the absence of an Altman Z-Score raises concern about bankruptcy risk, particularly given a high Debt/Equity ratio of 2.59. The stock trades at a premium valuation (P/E 57.88 vs. sector average 30.46) despite mixed earnings quality, with recent Q/Q EPS growth at +213% but year-over-year EPS down 5.3%. Insider selling totaling $56.66M in the last six months signals bearish sentiment from management. While revenue and earnings growth remain robust (29.6% and 59.3% YoY), the lack of cash flow data and high leverage undermine financial stability. The current price of $46.88 is significantly above both the Graham Number ($13.95) and intrinsic value estimate ($23.9), suggesting a substantial valuation premium driven by growth expectations.

The deterministic health and value scores are severely distressed, highlighted by a weak Piotroski F-Score of 2/9 and a current price ($9.75) that trades at a massive premium to both the Graham Number ($2.73) and Intrinsic Value ($2.95). While analysts maintain a 'buy' rating based on a low forward P/E of 9.63, the fundamental data reveals a critical sustainability crisis, most notably an unsustainable dividend payout ratio of 855%. Recent earnings performance has collapsed, with Q/Q EPS growth plummeting by 91.7%, coinciding with a bearish technical trend and a 44.3% decline over the last year.